Wilson Sonsini Goodrich & Rosati advised Totient on the deal. AbSci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, announced the acquisition...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aristea Therapeutics on the deal. Arena Pharmaceuticals, Inc. and Aristea Therapeutics, Inc. announced a strategic collaboration to advance the clinical...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aristea Therapeutics on the deal. Aristea announced the closing of a $63 million Series B financing led by Fidelity Management &...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Inspire Energy Capital on the deal. Shell New Energies US LLC, a subsidiary of Royal Dutch Shell plc, announced that...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Medallia on the deal. Latham & Watkins represented Blackstone Alternative Credit Advisors as the lead lender, as well as credit arms...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Carbon Health on the deal. Carbon Health announced that it raised $350 million. With the investment, Carbon Health, a leading...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Saranas on the deal, while Latham & Watkins represented Baird Capital. Houston, Texas-based Saranas announced a $12.8 million Series B...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins advised EnCap Investments L.P. on the deal. EnCap Investments L.P., a leading provider of growth capital to the independent sector of the U.S....
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP and Wilson Sonsini Goodrich & Rosati represented Erasca in the transaction. Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Leo Cancer Care on the deal. Leo Cancer Care, an innovative start-up that is set to change the face of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Blend on the deal while Goodwin Procter represented the underwriters. Blend Labs, Inc. announced the pricing of its initial public...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati, P.C. acted as legal counsel to Aurora, while Skadden, Arps, Slate, Meagher & Flom LLP advised Reinvent. Sullivan & Cromwell LLP...
You must be a Standard 1 Year member to access this content.
